ALDX compared with ELTX: revenue, margins and what each company keeps, and the suppliers and customers both name

ALDXAldeyra Therapeutics, Inc.

Mkt capRevenueRevenue

ELTXElicio Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ALDXAldeyra Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ALDX

0 of 3at or beyond implied

Reportimpliedrealized× implied

May 4 '23±13.6%▲+2.06%×0.15

Mar 9 '23±7.5%▲+7.19%×0.96

Nov 10 '22—▲+6.18%—

Aug 5 '22±19.4%▲+10.90%×0.56

ELTX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.7%▼−1.90%×0.10

= impliedALDX realized, solidELTX realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

ALDXAldeyra Therapeutics, Inc.

0.66▲+18.49%· post 0.59· delayed

Mkt cap$33.8M

ELTXElicio Therapeutics, Inc.

1.60▼−5.06%· post 1.60· delayed

After hoursNov 2 '26delayed

Mkt cap$44.2M

Compare

After hoursNov 2 '26delayed

ALDXAldeyra Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.

0.66▲+18.49%post 0.59delayed

Price

1.60▼−5.06%post 1.60delayed

$33.8M

Mkt cap

$44.2M

ALDX0.66▲+18.49%vsELTX1.60▼−5.06%After hoursNov 2 '26delayed